Vaginal Dysbiosis: Clinical Trials

5 trials for Vaginal Dysbiosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 not yet recruiting. 3 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Recruiting 1
Phase 21Recruiting 1
Phase 31Not yet recruiting 1

Follow Vaginal Dysbiosis: new trials by email Literature Review of Vaginal Dysbiosis trials Research Report on Vaginal Dysbiosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AUTOP 2: Screen-and-treat Strategy for Vaginal Flora Abnormalities by Molecular Biology in Pregnant Women at High Risk of Preterm Birth
Vaginal flora abnormalities screening and quantification using molecular biology technique, Azithromycin, Ceftriaxone - Bacterial Vaginosis, Vaginal Dysbiosis
Phase 3Not yet recruitingAssistance Publique Hopitaux De Marseille17942026-10-012026-08-27
Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle
FB-301, Placebo, Chlorhexidine (0.5%) Vaginal Cleanse - Vaginal Dysbiosis
Phase 2RecruitingFreya Biosciences ApS302026-07-222026-10-15
A Multicenter, Open, Comparative Study on Vaginal Dysbiosis in Premenopausal Women (DISPALOMA)
Palomacare® vaginal gel is a medical device with CE class IIa. - Vaginal Dysbiosis
Not applicableRecruitingProcare Health Iberia S.L.302024-12-122025-02-03
Feasibility of an Oral Intervention for Sexual Health in Transgender Men
Probiotic Group, Placebo Group - Vaginal Dysbiosis, Vaginal Disease
Not applicableCompletedColumbia University292024-08-142025-05-09
Transplantation of Vaginal Mikrobiome
Vaginal Microbiome Transplant, Vaginal Microbiome Transplant Placebo, No intervention - Vaginal Dysbiosis, Vaginal Microbiome
Not applicableCompletedCopenhagen University Hospital, Hvidovre3022021-06-012023-03-27

Narrower conditions

Dysbiosis (1)  ·  Premature Birth (1)  ·  Vaginal Diseases (1)  ·  Vaginosis, Bacterial (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Urogenital Diseases (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Infections (1)  ·  Obstetric Labor Complications (1)  ·  Obstetric Labor, Premature (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pregnancy Complications (1)  ·  Vaginal Diseases (1)  ·  Vaginitis (1)

Interventions

Azithromycin (1)  ·  Ceftriaxone (1)  ·  Chlorhexidine (1)  ·  Clotrimazole (1)  ·  Doxycycline (1)  ·  Metronidazole (1)  ·  Sodium Chloride (1)

Sponsors

Assistance Publique Hopitaux De Marseille (1)  ·  Columbia University (1)  ·  Copenhagen University Hospital, Hvidovre (1)  ·  Freya Biosciences ApS (1)  ·  Procare Health Iberia S.L. (1)

Countries

United States (2)  ·  Denmark (1)  ·  Spain (1)

Top investigators

Asa Radix, MD, PhD (1)  ·  Rupak Shivakoti, PhD (1)

Results publications

PMID 41905375

NIH funding

2023 (1)